Vigil Neuroscience, Inc.

NASDAQ:VIGL

7.99 (USD) • At close July 3, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q2
Revenue 000001.93400000000000000
Cost of Revenue 0000.1130.1130.1130.110.4740.3830.2740.2530.2460.23700.15100000
Gross Profit 000-0.113-0.1131.821-0.11-0.474-0.383-0.274-0.253-0.246-0.2370-0.15100000
Gross Profit Ratio 000000.94200000000000000
Reseach & Development Expenses 16.51118.66813.77215.5414.32616.78215.41514.90313.83412.19112.79112.09710.3659.1197.818.6486.7533.17722.260.197
General & Administrative Expenses 6.9586.4466.9046.9387.0897.0756.9067.016.9416.6824.8464.9454.9673.8582.9282.1281.1650.8820.8950
Selling & Marketing Expenses 000-0.113-0.113-0.11300000000000000
SG&A 6.9586.4466.9046.8256.9766.9626.9067.016.9416.6824.8464.9454.9673.8582.9282.1281.1650.8820.8950.184
Other Expenses 000-0.003-0.0020.002-0.003-0.007-0.005-0.009-0.026-0.005-0.004-0.008-0.002-0.592-0.275-0.177-1.1550
Operating Expenses 23.46925.11420.67622.36521.30223.74422.32121.91320.77518.87317.63717.04215.33212.97710.73810.7767.9184.05923.1550.381
Operating Income -23.469-25.114-20.676-22.478-21.415-23.857-22.321-21.913-20.775-18.873-17.637-17.042-15.332-12.977-10.738-10.776-7.918-4.059-23.155-0.381
Operating Income Ratio 00000-12.33600000000000000
Total Other Income Expenses Net 1.0561.2831.4181.2511.4751.6831.8261.7390.980.4170.1370.027-0.002-0.008-0.002-0.591-0.273-0.177-1.1550
Income Before Tax -22.413-23.831-19.258-21.227-19.94-22.174-20.495-20.174-19.795-18.456-17.5-17.015-15.334-12.985-10.74-11.367-8.191-4.236-24.31-0.381
Income Before Tax Ratio 00000-11.46500000000000000
Income Tax Expense 00000.072.901-0.11-1.746-1.045-32.791-0.137-0.0270.002-12.980.0020.590.2710.1771.1550
Net Income -22.413-23.831-19.258-21.227-19.94-22.174-20.495-20.174-18.7514.335-17.363-16.988-15.336-12.985-10.74-11.367-8.191-4.236-24.31-0.381
Net Income Ratio 00000-11.46500000000000000
EPS -0.49-0.57-0.47-0.52-0.5-0.57-0.53-0.52-0.490.37-0.52-0.6-0.58-0.46-0.38-0.54-0.39-0.2-1.15-0.014
EPS Diluted -0.49-0.57-0.47-0.52-0.5-0.57-0.53-0.52-0.490.37-0.52-0.6-0.58-0.46-0.38-0.54-0.39-0.2-1.15-0.014
EBITDA -23.469-25.001-20.562-22.365-21.302-23.744-22.211-21.802-20.71-18.852-17.616-17.024-15.314-12.962-10.726-10.77500-23.929-0.381
EBITDA Ratio 00000-12.27700000000000000